A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
This Phase III, multicenter, randomized, active-controlled, open-label trial is designed to
evaluate the efficacy, safety, and pharmacokinetics of rhuMAb VEGF when combined with
capecitabine compared with capecitabine alone in subjects with previously treated metastatic
breast cancer.